Jack Wright

Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study

К. Ray Chaudhuri, Jean‐Philippe Azulay, Per Odin et al. · Drugs - Real World Outcomes · 2024 · 83 citations · Full text

Social Sciences, Neurology, Pharmacoeconomics +17

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

Irene A. Malaty, Pablo Martínez‐Martín, К. Ray Chaudhuri et al. · BMC Neurology · 2022 · 43 citations · Full text

Public Health, Neurology, Clinical Pharmacology +14

Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States

Dee Lin, Kruti Joshi, Alexander Keenan et al. · Frontiers in Psychiatry · 2021 · 40 citations · Full text

Medicine, Psychiatry, Adult Psychiatry +16

Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States

Andrew Thach, Eddie Jones, Eric J. Pappert et al. · BMC Neurology · 2021 · 25 citations · Full text

Medicine, Health Sciences, Neurology +15

Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection

Heather Fitzgerald, Jason F. Shepherd, Hollie Bailey et al. · Neuropsychiatric Disease and Treatment · 2021 · 16 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16